Deepali Jain

Deepali Jain

Active Director Director DIN 09312390
DIN 09312390 First appointment Sep 2021 Primary industry E-Commerce
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Sep 2021
Shareholding value •••• Premium profile

About Deepali Jain

Data last updated:

Deepali Jain is a Director at Pharmagrowth Solutions Private Limited (since 2021). The company operates in E-Commerce. Pharmagrowth Solutions Private Limited reported revenue of ₹10.17 Cr (FY 2024).

DIN 09312390
Primary Designation Director
Industry E-Commerce
First Appointment 13 Sep 2021
Oldest Company Age 6 yrs
Largest company Pharmagrowth Solutions Private Limited · ₹10.17 Cr (FY 2024)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director13 Sep 20212020₹10.17 Cr (FY 2024)Active

Board colleagues of Deepali Jain

Directorship timeline

Open interactive timeline →
Pharmagrowth Solutions Private Limited
Premium access

Shareholding and investment profile for Deepali Jain

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Deepali Jain

Deepali Jain currently holds 1 directorship: Pharmagrowth Solutions Private Limited (Director, since 13 Sep 2021, revenue ₹10.17 Cr (FY 2024)).

Deepali Jain was first appointed on 13 Sep 2021 as Director at Pharmagrowth Solutions Private Limited.

The current boards of Deepali Jain's companies include Anmol Sureka (Pharmagrowth Solutions Private Limited), Sajal Jain (Pharmagrowth Solutions Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available